01460nam 2200397 a 450 991069703770332120230902162248.0(CKB)5470000002384526(OCoLC)609871343(EXLCZ)99547000000238452620100428d2009 ua 0engurmn|||||||||txtrdacontentcrdamediacrrdacarrierBrand-name prescription drug pricing[electronic resource] lack of therapeutically equivalent drugs and limited competition may contribute to extraordinary price increases : report to congressionals requesters[Washington, D.C.] :U.S. Govt. Accountability Office,[2009]1 online resource (ii, 35 pages)Title from PDF title screen (GAO, viewed Apr. 27, 2010)."December 2009.""GAO-10-201."Includes bibliographical references.Brand-name prescription drug pricing Prescription pricingBrand name productsPricesPrescription pricingGovernment policyUnited StatesPrescription pricing.Brand name productsPrices.Prescription pricingGovernment policyGPOGPOBOOK9910697037703321Brand-name prescription drug pricing3519753UNINA